Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Portfolio Pulse from Juan Spínelli
The global psychedelic drugs market is projected to grow from $4.88 billion in 2023 to $10.2 billion by 2028, driven by increased mental health awareness and regulatory changes. Companies like Pfizer, Johnson & Johnson, and Mydecine Innovations Group are advancing in this sector.
October 28, 2024 | 10:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson is advancing in the psychedelic drugs market, which is projected to grow significantly due to mental health awareness and regulatory changes.
Johnson & Johnson's involvement in the psychedelic drugs market positions it to benefit from the sector's projected growth, driven by mental health awareness and regulatory changes.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Mydecine Innovations Group is actively advancing in the psychedelic drugs sector, which is expected to grow significantly due to increased mental health awareness and regulatory changes.
Mydecine Innovations Group's focus on psychedelic drugs positions it to benefit from the sector's projected growth, driven by mental health awareness and regulatory changes.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Pfizer is actively advancing in the psychedelic drugs sector, which is expected to grow significantly due to increased mental health awareness and regulatory changes.
Pfizer's involvement in the psychedelic drugs market positions it to benefit from the sector's projected growth, driven by mental health awareness and regulatory changes.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70